<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

VEGI is a Potential Tumor Suppressor in RCC

While vascular endothelial growth inhibitor (VEGI) has been associated with tumor-related vasculature in certain malignancies, its implication in angiogenesis-dependent renal cell carcinoma (RCC) remains unknown.